CRM Publications

Emmerson E, Knox SM.  2018.  Salivary gland stem cells: A review of development, regeneration and cancer.Genesis. 56(5):e23211.

Boulter L, Lu W-Y, Forbes SJ.  2013.  Differentiation of progenitors in the liver: a matter of local choice.J Clin Invest. 123(5):1867-73.

Nerlov C.  2010.  Transcriptional and translational control of C/EBPs: the case for "deep" genetics to understand physiological function.Bioessays. 32(8):680-6.

Kadaja-Saarepuu L, Laos S, Jääger K, Viil J, Balikova A, Lõoke M, Hansson GC, Maimets T.  2008.  CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF.Oncogene. 27(12):1705-15.

Zheng B, Cao B, Crisan M, Sun B, Li G, Logar A, Yap S, Pollett JB, Drowley L, Cassino T et al..  2007.  Prospective identification of myogenic endothelial cells in human skeletal muscle.Nat Biotechnol. 25(9):1025-34.

Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, Peskett E, Sancho S, Smith AG, Withers DJ, Vanhaesebroeck B.  2006.  Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.Nature. 441(7091):366-70.

Prokhortchouk E, Hendrich B.  2002.  Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?Oncogene. 21(35):5394-9.

Brickman JM, Burdon T.  2002.  Pluripotency and tumorigenicity.Nat Genet. 32(4):557-8.